1. Home
  2. NTRA vs WDS Comparison

NTRA vs WDS Comparison

Compare NTRA & WDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • WDS
  • Stock Information
  • Founded
  • NTRA 2003
  • WDS 1954
  • Country
  • NTRA United States
  • WDS Australia
  • Employees
  • NTRA N/A
  • WDS N/A
  • Industry
  • NTRA Medical Specialities
  • WDS Oil & Gas Production
  • Sector
  • NTRA Health Care
  • WDS Energy
  • Exchange
  • NTRA Nasdaq
  • WDS Nasdaq
  • Market Cap
  • NTRA 24.9B
  • WDS 28.4B
  • IPO Year
  • NTRA 2015
  • WDS N/A
  • Fundamental
  • Price
  • NTRA $173.27
  • WDS $14.82
  • Analyst Decision
  • NTRA Strong Buy
  • WDS Hold
  • Analyst Count
  • NTRA 17
  • WDS 1
  • Target Price
  • NTRA $192.41
  • WDS N/A
  • AVG Volume (30 Days)
  • NTRA 1.1M
  • WDS 778.8K
  • Earning Date
  • NTRA 11-11-2025
  • WDS 08-18-2025
  • Dividend Yield
  • NTRA N/A
  • WDS 6.77%
  • EPS Growth
  • NTRA N/A
  • WDS 58.72
  • EPS
  • NTRA N/A
  • WDS 1.54
  • Revenue
  • NTRA $1,964,250,000.00
  • WDS $13,781,000,000.00
  • Revenue This Year
  • NTRA $24.28
  • WDS N/A
  • Revenue Next Year
  • NTRA $15.22
  • WDS N/A
  • P/E Ratio
  • NTRA N/A
  • WDS $9.67
  • Revenue Growth
  • NTRA 44.38
  • WDS 9.53
  • 52 Week Low
  • NTRA $117.27
  • WDS $11.26
  • 52 Week High
  • NTRA $183.00
  • WDS $17.76
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 59.76
  • WDS 33.35
  • Support Level
  • NTRA $157.43
  • WDS $14.93
  • Resistance Level
  • NTRA $173.62
  • WDS $15.36
  • Average True Range (ATR)
  • NTRA 5.35
  • WDS 0.18
  • MACD
  • NTRA 0.04
  • WDS 0.01
  • Stochastic Oscillator
  • NTRA 67.61
  • WDS 0.74

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About WDS Woodside Energy Group Limited

Incorporated in 1954 and named after the small Victorian town of Woodside, Woodside's early exploration focus moved from Victoria's Gippsland Basin to Western Australia's Carnarvon Basin. First LNG production from the North West Shelf came in 1984. BHP Billiton and Shell each had 40% shareholdings before BHP sold out in 1994 and Shell sold down to 34%. In 2017 Shell sold its entire shareholding. Woodside is one of the most LNG-leveraged companies globally.

Share on Social Networks: